{
    "Title": "Selective Inhibitors of Protozoan Protein N-myristoyltransferases as Starting Points for Tropical Disease Medicinal Chemistry Programs",
    "URL": "https://doi.org/10.1371/journal.pntd.0001625",
    "Published": "April 24, 2012",
    "Subject_Areas": [
        "Plasmodium",
        "Drug research and development",
        "Malaria",
        "Leishmania donovani",
        "Leishmaniasis",
        "Leishmania",
        "Protozoan infections",
        "Trypanosoma"
    ],
    "Authors": {
        "Andrew S. Bell": [
            "Worldwide Medicinal Chemistry, Pfizer Worldwide Research and Development, Kent, United Kingdom"
        ],
        "James E. Mills": [
            "Worldwide Medicinal Chemistry, Pfizer Worldwide Research and Development, Kent, United Kingdom"
        ],
        "Gareth P. Williams": [
            "High Throughput Screening Center of Emphasis, Pfizer Worldwide Research and Development, Kent, United Kingdom"
        ],
        "James A. Brannigan": [
            "Department of Chemistry, University of York, York, United Kingdom"
        ],
        "Anthony J. Wilkinson": [
            "Department of Chemistry, University of York, York, United Kingdom"
        ],
        "Tanya Parkinson": [
            "Opportunities for Partnership in Medicine, Pfizer Worldwide Research and Development, Kent, United Kingdom"
        ],
        "Robin J. Leatherbarrow": [
            "Institute of Chemical Biology, Department of Chemistry, Imperial College, London, United Kingdom"
        ],
        "Edward W. Tate": [
            "Institute of Chemical Biology, Department of Chemistry, Imperial College, London, United Kingdom"
        ],
        "Anthony A. Holder": [
            "Division of Parasitology, Medical Research Council National Institute for Medical Research, London, United Kingdom"
        ],
        "Deborah F. Smith": [
            "Department of Biology, University of York, York, United Kingdom"
        ]
    }
}